Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 45% ± 22% | |
lung | 11 studies | 26% ± 11% | |
eye | 8 studies | 32% ± 10% | |
peripheral blood | 6 studies | 25% ± 7% | |
heart | 5 studies | 25% ± 6% | |
intestine | 4 studies | 23% ± 6% | |
adipose | 4 studies | 35% ± 10% | |
liver | 4 studies | 30% ± 17% | |
kidney | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 10677.82 | 2642 / 2642 | 100% | 196.22 | 705 / 705 |
esophagus | 100% | 4600.68 | 1445 / 1445 | 100% | 64.26 | 183 / 183 |
ovary | 100% | 5834.24 | 180 / 180 | 100% | 81.53 | 430 / 430 |
prostate | 100% | 4710.47 | 245 / 245 | 100% | 78.33 | 502 / 502 |
stomach | 100% | 3220.36 | 359 / 359 | 100% | 66.28 | 286 / 286 |
breast | 100% | 6406.75 | 459 / 459 | 100% | 93.56 | 1117 / 1118 |
thymus | 100% | 6297.09 | 653 / 653 | 100% | 100.56 | 604 / 605 |
skin | 100% | 6170.04 | 1809 / 1809 | 100% | 112.21 | 471 / 472 |
kidney | 100% | 4277.25 | 89 / 89 | 100% | 67.98 | 899 / 901 |
bladder | 100% | 4906.00 | 21 / 21 | 100% | 67.19 | 502 / 504 |
lung | 100% | 5117.95 | 577 / 578 | 100% | 65.49 | 1151 / 1155 |
intestine | 100% | 4800.70 | 966 / 966 | 99% | 63.74 | 524 / 527 |
uterus | 100% | 6387.38 | 170 / 170 | 99% | 67.48 | 455 / 459 |
adrenal gland | 100% | 3728.17 | 258 / 258 | 98% | 94.72 | 226 / 230 |
pancreas | 94% | 1882.73 | 309 / 328 | 98% | 65.50 | 175 / 178 |
liver | 85% | 1320.84 | 191 / 226 | 87% | 28.82 | 352 / 406 |
adipose | 100% | 6675.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 47.26 | 29 / 29 |
spleen | 100% | 4157.26 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 55.11 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.06 | 1 / 1 |
blood vessel | 100% | 5524.92 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 70.74 | 79 / 80 |
heart | 95% | 2302.65 | 819 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 2980.07 | 850 / 929 | 0% | 0 | 0 / 0 |
muscle | 78% | 1272.28 | 625 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0051893 | Biological process | regulation of focal adhesion assembly |
GO_0097060 | Cellular component | synaptic membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043235 | Cellular component | receptor complex |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0016020 | Cellular component | membrane |
GO_0005001 | Molecular function | transmembrane receptor protein tyrosine phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPRA |
Protein name | Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Protein tyrosine phosphatase receptor type A Receptor-type tyrosine-protein phosphatase alpha (EC 3.1.3.48) |
Synonyms | PTPA PTPRL2 |
Description | FUNCTION: Tyrosine protein phosphatase which is involved in integrin-mediated focal adhesion formation (By similarity). Following integrin engagement, specifically recruits BCAR3, BCAR1 and CRK to focal adhesions thereby promoting SRC-mediated phosphorylation of BRAC1 and the subsequent activation of PAK and small GTPase RAC1 and CDC42 (By similarity). . |
Accessions | Q5JWG3 ENST00000430705.5 Q5JWG0 ENST00000356147.3 [P18433-6] ENST00000216877.10 [P18433-6] P18433 A0A1S5UZ22 Q5JWG2 ENST00000431048.5 ENST00000399903.7 [P18433-5] ENST00000455631.5 ENST00000318266.9 [P18433-6] |